cancer chemotherapy and pharmacology

cancer chemother pharmacol ISSN 1432-0843 381 views

Indexed In

scopus ncbi ulakbim sci

Publications

5

ULAKBİM MEP: 0.695 Ödeme: 3475 Yılı: 2020

Details

Abbreviated Name: cancer chemother pharmacol
ISSN: 1432-0843

Publications/Year

Top Clicked Bibliographies from Search

1

Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab.

2019 315 clicks

4

Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project

2019 304 clicks

2

CDA and MTHFR polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine-based chemotherapy

2019 286 clicks

3

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study.

2017 260 clicks

5

Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine (Cancer Chemotheraphy and Pharmacology DOI: 10.1007/s00280-007-0636-z)

2008 72 clicks